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Purpose We report our initial experience with the newly released ultra-
high density (UHD) electroanatomical mapping system (Rhythmia, Boston
Scientific) for arrhythmias. 
Methods All procedures using the multielectrodes catheter (Orion, Boston
Scientific) in our institution, for arrhythmias mapping were analyzed. Proce-
dure and fluoroscopy times were also assessed.
Results 20 patients were included (67,9±13 y) for radiofrequency ablation of
accessory pathway (n=2) / typical flutter (n=5) / atrial fibrillation (AF n=2) / post-
AF ablation left atrial tachycardia (AT n=6) / focal AT (n=2)/ left and right ven-
tricular ectopies (n=3). 63 maps (3,15 maps per patient) were acquired within a
mean mapping time of 18±10min per map, including a mean number of
10024,3±9371 electrograms per map (Figure): RA maps (flutter=12; sinus rhythm
SR=14; coronary sinus CS pacing=4); left atrial maps (during tachycardia=18;
SR=3; CS pacing=4); right ventricular maps (n=4); left ventricular maps (during
tachycardia=3; pacing=1). Acute success was achieved in 19/20 patients. In one
patient, the ablation could not be performed in the absence of clinical ectopies.
Total procedure and fluoroscopy times were respectively 232±78min and 15,9±8
min. No periprocedural complications were noticed.
Conclusion UHD electroanatomical endocardial mapping can be safely
performed in both atria and ventricles and allows fast and accurate mapping.
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Purpose of study to collect history of patients with preexcitation syndrome
(PS)-related adverse event (AE) and evaluate their risk factors. Classicaly
male sex, multiple accessory pathways (AP) and at electrophysiological study
(EPS), refractory period (RP) <250ms and shortest RR interval during atrial
fibrillation (AF) <250ms are signs of risk of AE.
Methods AE occurred in 83 among a population of 970 patients consecu-
tively recruited for a PS (8.5%) (resuscitated sudden death (n=8), or docu-
mented AF conducted with a rapid rate over AP (>300 bpm), cause of syncope
and requiring cardioversion (17) or drug (58). ECG, Holter monitoring and
EPS in control state (CS) and after isoproterenol were performed.
Results Patients with AE were older than remaining patients (40±8.5 vs
33±17) (p 0.0002). Male gender did not differ significantly (71 vs 61%)(p 0.06).
ECG in sinus rhythm was normal or near normal in 20 patients with AE (24%)
more frequently than in patients without AE (9%)(p 0.0001). Intermittent PS
was seen only in patients without AE. At EPS atrioventricular reentrant tachy-
cardia (AVRT) was induced as frequently in patients with AE as in patients
without AE (60% vs 53.5%)(0.22). All other electrophysiological data differ sig-
nificantly (p 0.0001): maximal rate conducted over AP was more rapid in
patients with AE (262±50 bpm vs 183±65 in CS, 302±39 vs 228.5±69 after iso-
proterenol). AP effective refractory period was shorter in patients with AE
(232±34 vs 292±73 in CS, 197±29 vs 232±50ms after isoproterenol); AF was
induced more frequently in patients with AE (72 vs 19.5%). Signs of malig-
nancy at EPS were noted in all but 4 patients (sensitivity 95%).
Conclusion If electrophysiological data evaluated in CS and after iso-
proterenol have high sensitivity (95%) to predict PS-related adverse event, the
detection of PS can be difficult. In 20% of patients who presented with an
adverse event, the diagnosis of PS was not made because ECG in sinus
rhythm was normal. 
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Background Radiofrequency ablation (RFA) is the only curative treatment
for typical atrial flutter (AFL) and allows stopping antiarrhythmic drugs. How-
ever, management of long-term anticoagulant therapy (LT ACT) remains unclear,
especially in lone AFL successfully treated and CHA2DS2VASc score ≥1.
Abstract 0340 – Figure: Ultra high density left atrial macro reentry map
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